
S5-26.2 – Looking Back at TLM2024: Patient Genotyping and MASH Clusters
This conversation starts by asking whether approval of two drugs for use without biopsy will challenge MASH trial recruitment and goes on to look at recent studies discussing patient genotyping and clustering.








